Genetically modified bacillus subtilis strain, optimized vectors, and uses thereof

US12012624B2 · kind B2 · utility

Assignee

• Roquette Freres · FR

Inventors

• Sébastien MAUBOURGUET · Lompret, FR
• Sophie Huchette · Béthune, FR
• Claudia Borgmeier · Bensheim, DE
• Guido Meurer · Seeheim-Jugenheim, DE

Key dates

• Filing date: Nov 6, 2018
• Grant date: Jun 18, 2024
• Expiry date: Oct 11, 2041

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Y501/03
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

A genetically modified Bacillus subtilis strain has been transformed with an optimized vector, mainly for producing a D-psicose 3-epimerase.